Neonatal citrullinemia treatment with alpha keto-analogues improved outcomes, reducing severe brain and liver pathology. Untreated infants experienced rapid decline, indicating potential in utero damage.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: